Detalhe da pesquisa
1.
The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation.
Am Heart J
; 225: 69-77, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32474206